Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide
about
DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody inductionPeptide Vaccine: Progress and ChallengesInduction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.Dendritic cells efficiently induce protective antiviral immunity.In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunityDelivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytesDevelopment of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelGeneration of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.Extracellular processing of peptide antigens that bind class I major histocompatibility moleculesMemory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.T cell priming versus T cell tolerance induced by synthetic peptides.Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro.Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge.Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsSimian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathologyPoliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regionsDesign and development of synthetic peptide vaccines: past, present and future.Skin test to assess virus-specific cytotoxic T-cell activityCationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathwayPeptide-based vaccines for cancer: realizing their potential.On the role of antigen in maintaining cytotoxic T-cell memoryPeptide-induced antiviral protection by cytotoxic T cells.Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes.
P2860
Q24671114-6E797B48-8713-405D-8273-9DC8AFC42043Q26851329-1C05C91A-EC4C-46F7-B390-F1796A28EB3EQ33595975-4EB57857-4377-4BEA-9276-DE2A39703D8AQ33643167-746E8F79-002F-486D-A266-C6268F81429BQ33782672-D8D9D1D2-F4B0-4F6F-9AA5-14696647A85EQ33806244-131444FD-EB54-4F30-AD89-F1B9CF9E3A9BQ33852549-082D72E5-FA47-4144-802F-B020B61EA377Q33902103-D721A713-382D-449B-982D-A5CE265AD59DQ34195888-1093D0EA-263E-4F09-A7DC-DCC02DAE6358Q34229490-DBEB84CE-0F3A-459F-AC6A-725CC4F08E26Q34398787-A0CE9B26-1E66-4DD9-9D49-152134015430Q34527878-2A7EDF16-A839-473E-89F1-45A2AB187D66Q34975904-CCADDD73-58BB-4B4B-A51D-F3A2B6A81ED1Q34998462-36E57B0C-9BB3-47D5-8A1F-9BAD9190D8B4Q35441983-D778373F-2A97-479D-9FC7-3030557C241DQ35833323-6A0D7AA3-0980-46E2-BD37-76E006248AABQ36084898-629C5F82-D214-40A9-948C-8C1D48B2FFEDQ36119828-48B4A406-2B4D-45DE-9401-780E9EEDDB6FQ36231285-97DE8FE2-E97E-4273-815D-6567C9F6D48BQ36284560-646A7853-6951-449B-BBB4-4916CE02DF29Q36365135-D752744D-9CCA-41A8-BF3E-4FDD2CE3FB6BQ36377398-6D3EFA26-1218-4C0D-90D3-9DC7CA632012Q36478934-D9D3E4EC-0349-4123-96C9-8A93F79C650AQ36636890-807E2700-FC0D-4E4E-AE7F-289F09196BA5Q36639515-9EB8F2DF-5DFB-4100-946B-31335224C76FQ36649875-B13DEA0F-2AC4-4F17-AC16-8B4126E653D4Q36650065-7C21EDEF-C7EF-4D37-8CCE-B2C65EE276FDQ36654693-9B0AD39B-E824-4AA1-AFF0-61A8C852535BQ36659320-5E480F1F-E63F-4B49-A468-40DF40301C66Q36687045-6139467D-678F-44DF-9E1C-42F01199AD67Q36690788-0F5B97DC-EA23-4FC7-8521-D9A4E9388BFBQ36702229-6E45EC55-BE97-4806-BEC4-C9BCE56C4AE0Q36899093-020948DC-18F8-4D6B-9F9A-32B157E13170Q37163268-5462152A-4B13-4A50-BF4E-E8C207C304FFQ37170547-5B16F6E5-D95D-4F5D-8280-F004925F6DAFQ37340462-8DAEDC6B-D6DC-43B7-B6F2-A8E9C85ED70BQ37361402-D1897270-3BA0-4B1E-B3F8-5F6FB05741ECQ37390829-ACAA21CD-E82B-468A-A331-94ACDB566E7CQ37434689-DE036392-90A8-4F93-B2E1-CBB5ED820969Q37436836-2B914EA2-0FFA-49F1-B23F-CB370058C7C5
P2860
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@ast
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@en
type
label
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@ast
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@en
prefLabel
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@ast
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@en
P2093
P2860
P356
P1476
Antiviral cytotoxic T cell res ...... with a free synthetic peptide
@en
P2093
Hengartner H
Zinkernagel RM
P2860
P304
P356
10.1084/JEM.171.5.1815
P407
P577
1990-05-01T00:00:00Z